(19)
(11) EP 1 567 506 A2

(12)

(88) Date of publication A3:
16.09.2004

(43) Date of publication:
31.08.2005 Bulletin 2005/35

(21) Application number: 03768789.4

(22) Date of filing: 10.11.2003
(51) International Patent Classification (IPC)7C07D 239/94, C07D 215/42, A61K 31/517, A61K 31/4706, A61P 31/18
(86) International application number:
PCT/US2003/035670
(87) International publication number:
WO 2004/046101 (03.06.2004 Gazette 2004/23)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 20.11.2002 US 427544 P

(71) Applicant: Array Biopharma, Inc.
Boulder, CO 80301 (US)

(72) Inventors:
  • WALLACE, Eli
    Lyons, CO 80540 (US)
  • TOPALOV, George
    Superior, CO 80027 (US)
  • ZHAO, Qian
    Superior, CO 80027 (US)
  • LYSSIKATOS, Joseph P.
    Superior, CO 80027 (US)

(74) Representative: Gillard, Richard Edward et al
Elkington and Fife LLP, Prospect House 8 Pembroke Road Sevenoaks,
Kent TN13 1XR
Kent TN13 1XR (GB)

   


(54) CYANOGUANIDINES AND CYANOAMIDINES AS ERBB2 AND EGFR INHIBITORS